Bottom line
MSGCX vs FSSNX: the short answer
MSGCX (Meridian Small Cap Growth Fund) and FSSNX (Fidelity Small Cap Index Fund) are both mutual funds.
But FSSNX is far broader, holding 1,966 positions to 100 for MSGCX, so beyond the top names it adds exposure MSGCX doesn't have.
FSSNX is cheaper at 0.025% vs 2.26% — a difference of $223 a year per $10,000 invested.
Over five years, FSSNX returned +6.2% a year vs −0.6% for MSGCX (reporting dates differ).
Updated Nov 19, 2026
MSGCX vs FSSNX side by side
| MSGCX | FSSNX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Meridian | Fidelity |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 2.26% | 0.025% |
| Annual cost per $10k | $226 | $2.5 |
| 10-yr cost on $10k (prospectus) | $2,402 | $32 |
| Max front load | 0% | — |
| 12b-1 fee | 1% | 0% |
| 1-yr return | −2.3% | +12.9% |
| 5-yr return (annualized) | −0.6% | +6.2% |
| 10-yr return (annualized) | +7.7% | +9.8% |
| Best quarter | — | +31.3% |
| Worst quarter | — | −30.6% |
| Net assets (fund) | $272.9M | $34.1B |
| Number of holdings | 100 | 1,966 |
| Portfolio turnover | 62% | 2% |
| Returns as of | Dec 31, 2025 | Jun 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
MSGCX and FSSNX share none of their top holdings.
MSGCX top 10
- Stit Govt And Agency Inst — 6.34%
- Axogen Inc — 3.19%
- Federal Signal Corp — 2.33%
- Hinge Health Inc — 2.26%
- Goldman Sachs Trust — 2.17%
- Veracyte Inc — 2.11%
- Consensus Cloud Solutions Inc — 2.07%
- Apartment List Inc. Series D Preferred Stock — 2.02%
- Definium Therapeutics Inc — 1.99%
- Spx Technologies Inc — 1.98%
FSSNX top 10
- Fidelity Revere Street Trust — 8.41%
- Fidelity Revere Street Trust — 0.41%
- Moog Inc — 0.36%
- Hut 8 Corp — 0.36%
- Umb Financial Corp — 0.35%
- Cytokinetics Inc — 0.33%
- Viasat Inc — 0.31%
- Brightspring Health Services Inc — 0.31%
- Glaukos Corp — 0.31%
- Caretrust REIT Inc — 0.31%
FAQ
What is the difference between MSGCX and FSSNX?
Which is cheaper, MSGCX or FSSNX?
Should I own both MSGCX and FSSNX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.